We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

98 hedge funds and large institutions have $798M invested in G1 Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

20% more capital invested

Capital invested by funds: $664M → $798M (+$134M)

0% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 18

6% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 34

1% less funds holding

Funds holding: 99 → 98 (-1)

94% less call options, than puts

Call options by funds: $248K | Put options by funds: $4.29M

Holders
98
Holders Change
-1
Holders Change %
-1.01%
% of All Funds
1.93%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
18
Increased
32
Reduced
34
Closed
18
Calls
$248K
Puts
$4.29M
Net Calls
-$4.05M
Net Calls Change
+$327K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$9.91M
2
State Street
State Street
Massachusetts
+$5.32M
3
RG
Redmile Group
California
+$5.21M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.44M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.62M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$27M
2
RPAM
Rhenman & Partners Asset Management
Sweden
-$6.37M
3
Millennium Management
Millennium Management
New York
-$2.78M
4
Morgan Stanley
Morgan Stanley
New York
-$2.13M
5
Goldman Sachs
Goldman Sachs
New York
-$1.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$3.55M +$47.3K +2,024 +2%
N
27
Nuveen
North Carolina
$3.48M -$43.1K -1,841 -1%
Citadel Advisors
28
Citadel Advisors
Florida
$3.42M +$2.62M +111,852 +638%
BBA
29
Baker Bros. Advisors
New York
$3.36M – – –
VOYA Investment Management
30
VOYA Investment Management
Georgia
$2.99M -$1.83M -78,147 -41%
Ameriprise
31
Ameriprise
Minnesota
$2.1M +$265K +11,312 +17%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$2.06M +$250K +10,700 +16%
AA
33
ALPS Advisors
Colorado
$2M +$19.6K +840 +1%
Morgan Stanley
34
Morgan Stanley
New York
$1.84M -$2.13M -91,106 -57%
Two Sigma Investments
35
Two Sigma Investments
New York
$1.77M +$1.3M +55,491 +488%
Two Sigma Advisers
36
Two Sigma Advisers
New York
$1.56M +$962K +41,116 +227%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$1.37M -$25.4K -1,085 -2%
Allianz Asset Management
38
Allianz Asset Management
Germany
$1.36M -$391K -16,710 -25%
State of Wisconsin Investment Board
39
State of Wisconsin Investment Board
Wisconsin
$1.34M – – –
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.33M +$25.7K +1,100 +2%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$1.2M -$7.37K -315 -0.7%
AllianceBernstein
42
AllianceBernstein
Tennessee
$1.19M -$60.8K -2,600 -5%
Barclays
43
Barclays
United Kingdom
$1.13M +$878K +37,531 +703%
BC
44
Birchview Capital
Vermont
$1.06M – – –
WG
45
Winton Group
United Kingdom
$1.05M +$928K +39,675 New
Rafferty Asset Management
46
Rafferty Asset Management
New York
$995K -$270K -11,557 -23%
TD Asset Management
47
TD Asset Management
Ontario, Canada
$945K -$131K -5,600 -14%
BWA
48
BDO Wealth Advisors
Florida
$931K – – –
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$862K -$112K -4,800 -13%
CM
50
Caption Management
Oklahoma
$748K +$661K +28,269 New
1
2
3 4 5

GTHX Hedge Fund Activity: Q4 2019 in Review

98 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q4 2019, worth a combined $798M — up 20% from $664M a quarter earlier.

Fund positioning in GTHX was balanced in Q4 2019: 18 funds opened new positions, 18 closed out, 32 added to existing stakes and 34 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $9.91M. The largest seller was Franklin Resources, exiting entirely with an estimated $27M sold.

  • 98 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q4 2019, down from 99 in Q3 2019.
  • Funds reported $798M of G1 Therapeutics, Inc. Common Stock stock for Q4 2019, up 20% quarter-over-quarter.
  • 18 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q4 2019 and 18 closed out, a net change of 0 holders.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q4 2019 was JP Morgan Chase, an estimated $9.91M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q4 2019 was Franklin Resources, an estimated $27M sold.

Based on aggregated 13F filings for Q4 2019.